Navigation Links
Porter Novelli Named Agency of Record for Prix Galien USA Awards
Date:6/29/2011

NEW YORK, June 29, 2011 /PRNewswire/ -- Global public relations leader Porter Novelli today announced that it has been named agency of record for the Prix Galien USA Awards, which recognize excellence in biopharmaceutical research and development that has significantly improved the human condition. Porter Novelli will be responsible for raising awareness of the award in the U.S. and driving volume of submissions.

The Prix Galien is internationally renowned for recognizing the development of innovative medicines and medical technologies. Judged by a prestigious committee of scientists and clinicians, the Prix Galien is considered the industry's highest accolade. The awards are presented in the following categories, in which one to three prizes are given: Best Pharmaceutical Agent, Best Biotechnical Product and Best Medical Device.

"Innovation in medicine is something that needs to be nurtured, acknowledged and rewarded," said Susan Hayes, global director, health, Porter Novelli. "Porter Novelli is pleased to support the Prix Galien's commitment to progress in health and medicine, a goal that everyone in the health care community shares."

The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2011 Prix Galien USA Awards will be held on September 27, 2011 at the American Museum of Natural History in New York City.

As part of the events that take place around the awards, Peter Pitts, director of global regulatory and health policy at Porter Novelli, will participate in the panel discussion, "What is 'Value' and How Can it be Measured and Demonstrated in Therapeutic Innovations? Breaking Down the Barriers of the Past."

About Porter Novelli

A global public relations leader, Porter Novelli was founded in 1972 and is a part of Omnicom Group Inc. (NYSE: OMC). In 90 offices in nearly 60 countries, Porter Novelli combines the power of immersion with the rigor of research to create deep human insights that enable the agency to transform the opinions, beliefs and behaviors of those who matter most to its clients. For additional information, please visit www.porternovelli.com.

Contact:
Catherine Sullivan
Catherine.Sullivan@porternovelli.com
212-601-8315


'/>"/>
SOURCE Porter Novelli
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
4. Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
7. Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
8. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Robert Kline, President & CEO, Medivance Named Ernst & Young Entrepreneur Of The Year® 2011 Regional Award Winner
11. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials ... combine to progress molecular radiotherapy imaging. In molecular ... to accurately quantify the radiation absorbed by those patients undergoing ... of this radiotherapy treatment has been available — that is, ... ...
(Date:7/5/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade cell and tissue hypothermic storage ... that it has reached an agreement with WAVI Holding ... modify its existing credit facility effective June 30, 2017. ... to exchange its existing $4.25 million credit facility, including ...
(Date:6/30/2017)... (AVACEN) announced the publication of new research in the peer-reviewed Fibromyalgia ... AVACEN Treatment Method to significantly reduce the widespread pain symptom ... ... ... to 400 million people worldwide according to The National Fibromyalgia Association. ...
Breaking Medicine Technology:
(Date:7/21/2017)... Norwalk, Connecticut (PRWEB) , ... July 21, 2017 , ... ... data from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in ... quarter of 2017, and up 15% from the 20 announced deals in the year-ago ...
(Date:7/21/2017)... NJ (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, ... Day Center at Somerset Hills , a service available through the nonprofit home ...
(Date:7/21/2017)... ... ... West Dermatology is pleased to announce the newest addition to their Fresno, ... will join West Dermatology’s large network of medical and cosmetic dermatology practices, bringing with ... more. She graduated from the University of Florida College of Medicine Physician Assistant Program ...
(Date:7/20/2017)... ... , ... TransPixel Volume 2 is a set of transitions that create a ... isolates horizontal and vertical lines of pixels and sorts their pixels by darkness, brightness, ... and can be changed using a drop-down menu. Create amazing and artistic transitions using ...
(Date:7/20/2017)... ... 2017 , ... Coats Rose, P.C. , a business ... expansion to the Midwest with the establishment of the firm’s new Cincinnati office. ... of counsels, John Peck and Robert Bruns, will establish and anchor Coats Rose’s ...
Breaking Medicine News(10 mins):